Article info

Download PDFPDF
9 Routine use of glycoprotein IIB/IIIA inhibitors is associated with improved survival in primary PCI

Authors

Citation

Orzalkiewicz M, Hodson J, Ludman P, et al
9 Routine use of glycoprotein IIB/IIIA inhibitors is associated with improved survival in primary PCI

Publication history

  • First published November 27, 2017.
Online issue publication 
November 27, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.